Literature DB >> 10226219

Benefits of ambulatory blood pressure monitoring in the design of antihypertensive drug trials.

.   

Abstract

REVIEW IN DEPTH: Ambulatory blood pressure monitoring (ABPM) offers substantial advantages over conventional clinic measurement in the assessment of antihypertensive agents. There is a greater reproducibility of an average blood pressure taken from multiple readings,s and in the setting of a clinical trial this translates into increased precision of the assessment of mean antihypertensive effect. The temporal profile of blood pressure and the antihypertensive effect of an agent can be studied directly, and times of the day of particular clinical importance, such as the end of the dosing period and the early morning period, can be studied more easily than for conventional blood pressure measurement. ABPM reduces the size of any placebo effect on blood pressure to very low values, and it can be used to exclude white-coat hypertensives from clinical trials, thereby reducing the noise in a clinical trial. The role of ABPM in drug evaluation looks set to increase further with new developments in blood pressure measurement technology.

Entities:  

Year:  1996        PMID: 10226219

Source DB:  PubMed          Journal:  Blood Press Monit        ISSN: 1359-5237            Impact factor:   1.444


  5 in total

Review 1.  Importance of various methods of blood pressure measurement in clinical trials.

Authors:  P Palatini
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

2.  Desoxycorticosterone pivalate-salt treatment leads to non-dipping hypertension in Per1 knockout mice.

Authors:  K Solocinski; M Holzworth; X Wen; K-Y Cheng; I J Lynch; B D Cain; C S Wingo; M L Gumz
Journal:  Acta Physiol (Oxf)       Date:  2016-10-03       Impact factor: 6.311

3.  Identification of dietary patterns associated with blood pressure in a sample of overweight Australian adults.

Authors:  S Anil; K E Charlton; L C Tapsell; Y Probst; R Ndanuko; M J Batterham
Journal:  J Hum Hypertens       Date:  2016-03-24       Impact factor: 3.012

4.  Ambulatory blood pressure monitoring in resistant hypertension.

Authors:  Dimitrios Syrseloudis; Ioannis Andrikou; Eirini Andrikou; Kyriakos Dimitriadis; Christodoulos Stefanadis
Journal:  Int J Hypertens       Date:  2011-04-05       Impact factor: 2.420

5.  STK39 polymorphisms and blood pressure: an association study in British Caucasians and assessment of cis-acting influences on gene expression.

Authors:  Michael S Cunnington; Chris Kay; Peter J Avery; Bongani M Mayosi; Mauro Santibanez Koref; Bernard Keavney
Journal:  BMC Med Genet       Date:  2009-12-14       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.